Alx Oncology Stock Forecast - Period Momentum Indicator
| ALXO Stock | USD 1.47 0.06 4.26% |
Alx Stock Forecast is based on your current time horizon.
Alx |
| Check Alx Oncology Volatility | Backtest Alx Oncology | Information Ratio |
Alx Oncology Trading Date Momentum
| On November 26 2024 Alx Oncology Holdings was traded for 1.47 at the closing time. The top price for the day was 1.60 and the lowest listed price was 1.43 . There was no trading activity during the period 0.0. Lack of trading volume on November 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.72% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Alx Oncology to competition |
Other Forecasting Options for Alx Oncology
For every potential investor in Alx, whether a beginner or expert, Alx Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alx. Basic forecasting techniques help filter out the noise by identifying Alx Oncology's price trends.View Alx Oncology Related Equities
| Risk & Return | Correlation |
Alx Oncology Holdings Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Alx Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Alx Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Alx Oncology Market Strength Events
Market strength indicators help investors to evaluate how Alx Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alx Oncology shares will generate the highest return on investment. By undertsting and applying Alx Oncology stock market strength indicators, traders can identify Alx Oncology Holdings entry and exit signals to maximize returns.
Alx Oncology Risk Indicators
The analysis of Alx Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alx Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.4 | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Alx Oncology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alx Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will appreciate offsetting losses from the drop in the long position's value.Moving together with Alx Stock
| 0.71 | ME | 23Andme Holding | PairCorr |
| 0.71 | VALN | Valneva SE ADR | PairCorr |
| 0.73 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Alx Stock
| 0.74 | KZR | Kezar Life Sciences | PairCorr |
| 0.56 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.36 | MDGL | Madrigal Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Alx Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alx Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alx Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alx Oncology Holdings to buy it.
The correlation of Alx Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alx Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alx Oncology Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alx Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Alx Oncology to cross-verify your projections. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.